Previous Article in Journal
Predictors of Residual Pulmonary Vascular Obstruction after Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality
Previous Article in Special Issue
Endovascular Treatment of Abdominal Aortic Aneurysm: Impact of Diabetes on Endoleaks and Reintervention
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Understanding Type II Endoleak: A Harmless Imaging Finding or a Silent Threat?

by
Georgios Koudounas
1,
Stefanos Giannopoulos
2,
Nektarios Charisis
3 and
Nicos Labropoulos
2,*
1
Vascular Unit, 5th Department of Surgery, Aristotle University Medical School, Hippokratio Hospital, 54642 Thessaloniki, Greece
2
Division of Vascular and Endovascular Surgery, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY 11794, USA
3
Department of Radiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(14), 4250; https://doi.org/10.3390/jcm13144250 (registering DOI)
Submission received: 18 June 2024 / Revised: 6 July 2024 / Accepted: 17 July 2024 / Published: 20 July 2024
(This article belongs to the Special Issue Challenges in Abdominal Aortic Aneurysm)

Abstract

Type II endoleak (T2EL) represents a challenging clinical entity following endovascular abdominal aortic aneurysm repair (EVAR). Although several studies have suggested that T2ELs are related to an increased risk of aneurysm sac growth and subsequent rupture, the exact role that T2ELs play in long-term outcomes remains debatable. Understanding the pathophysiology, diagnostic modalities, and management options of T2ELs is important for patients’ safety and proper resource utilization. While conservative management may be suitable for asymptomatic patients with a stable aneurysm size, interventional approaches, including transarterial embolization, direct sac puncture embolization and open conversion have been described for patients with persistent T2EL associated with sac expansion. However, more research is needed to better determine the clinical benefit of such interventions. A thorough evaluation of all endoleak types before T2EL treatment would be reasonable for patients with T2ELs associated with sac expansion. Further studies are needed to refine treatment strategies aimed at minimizing T2EL-related complications. Collaborative efforts among vascular specialists, radiologists, and researchers are of paramount importance to address this ongoing clinical challenge.
Keywords: type II endoleak; post-EVAR complication; transarterial embolization; sac embolization; aneurysmal sac expansion type II endoleak; post-EVAR complication; transarterial embolization; sac embolization; aneurysmal sac expansion

Share and Cite

MDPI and ACS Style

Koudounas, G.; Giannopoulos, S.; Charisis, N.; Labropoulos, N. Understanding Type II Endoleak: A Harmless Imaging Finding or a Silent Threat? J. Clin. Med. 2024, 13, 4250. https://doi.org/10.3390/jcm13144250

AMA Style

Koudounas G, Giannopoulos S, Charisis N, Labropoulos N. Understanding Type II Endoleak: A Harmless Imaging Finding or a Silent Threat? Journal of Clinical Medicine. 2024; 13(14):4250. https://doi.org/10.3390/jcm13144250

Chicago/Turabian Style

Koudounas, Georgios, Stefanos Giannopoulos, Nektarios Charisis, and Nicos Labropoulos. 2024. "Understanding Type II Endoleak: A Harmless Imaging Finding or a Silent Threat?" Journal of Clinical Medicine 13, no. 14: 4250. https://doi.org/10.3390/jcm13144250

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop